Overview

Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors

Status:
Completed
Trial end date:
2008-03-28
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety in depressive patients who did not respond sufficiently to selective serotonin re-uptake inhibitors (SSRI).
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Bupropion
Serotonin
Serotonin Uptake Inhibitors